EUR Million / Keywords (Scope/ Impact)
1.1 Understanding health, well-being and disease / SC1-PM-01-2016 – Multi omics for personalised therapies addressing diseases of the immune system / 13 Apr 2016 / 12-15 / Use data; imaging; functional analysis – relevant biomarkers for developing new targeted therapies
SC1-PM-02-2017- New concepts in patient stratification (2 stage) / 4 Oct 2016
11 Apr 2017 / 4-6 / Integrate data; systems biomedicine; -omics; modelling & analysis; validate through clinical studies
SC1-PM-03-2016 – Diagnostic characterisation of rare diseases / 13 Apr 2016 / 10-12 / Molecular; genomics; -omics; bioinformatics for data sharing; common standards to classify rare diseases
SC1-PM-04-2016 - Networking and optimising the use of population and patient cohorts at EU level / 13 Apr 2016 / 8-10 / Exploit existing cohorts; new (ICT) technologies & data types (eHealth records); knowledge – health & disease
1.2. Preventing disease / SC1-PM-05-2016 - The European Human Biomonitoring Initiative [Co-Fund] / 13 Apr 2016 / 50 / For research funders only. Monitor & assess human exposure to chemicals; potential health impacts.
SC1-PM-06-2016 - Vaccine development for malaria and/or neglected infectious diseases / 13 Apr 2016 / 3-20 / Address bottlenecks in discovery, preclinical & early clinical development of new vaccine candidates; large or small scale
SC1-PM-07-2017 - Promoting mental health & well-being in the young (2 stage) / 4 Oct 2016
11 Apr 2017 / 2-4 / Population-oriented primary prevention interventions; beyond SOTA, medical & social; <25 year olds/ sub-group
1.3 Treating and managing diseases / SC1-PM-08-2017 - New therapies for rare diseases (2 stage) / 4 Oct 2016
11 Apr 2017 / 4-6 / Clinical trials: ‘EC orphan’ substances; strategy for patient recruitment; EMA protocol; SMEs; prelim results/ feasibility
SC1-PM-09-2016 - New therapies for chronic diseases / 13 Apr 2016 / 4-6 / Clinical trials: novel or available therapies; non-communicable/infectious disease; prelim results/ feasibility
SC1-PM-10-2017 - Comparing the effectiveness of existing healthcare interventions in the adult population (2 stage) / 4 Oct 2016
11 Apr 2017 / 4-6 / Public health importance; compare interventions, preventive or therapeutic; core outcome set; cost-effectiveness analysis
SC1-PM-11-2016+2017 - Clinical research on regenerative medicine / 13 Apr 2016
11 Apr 2017 / 4-6
4-6 / Clinical trials (later phase): regen medicine therapy ready for in-patient; prelim results; justify disease choice
1.4 Active ageing & self-management of disease / SC1-PM-12-2016 – PCP - eHealth innovation in empowering the hospitalised patient / 16 Feb 2016 / 4 (EU contribution) / Transition to new services/ better integration of existing services through ICT (user acceptance; training; patient)
SC1-PM-13-2016- PPI for deployment and scaling up of ICT solutions for active and healthy ageing / 16 Feb 2016 / 2-5 (EU contribution) / Deploy active healthy ageing solutions at a large scale in different EU regions; ICT-based solutions
SC1-PM-14-2016 – EU-Japan cooperation on novel ICT Robotics based solutions for active and healthy ageing at home or in care facilities / 19 Jan 2016 / 5 / Develop & demonstrate advanced ICT robotics; improve social situations; empower older people
SC1-PM-15-2017- Personalised coaching for well-being & care of people as they age / 31 Jan 2017 / 3-4 / Proof of concept: radically new solution for virtual coach; intelligent-emotional computing; user friendly
1.5 Methods and data / SC1-PM-16-2017- In-silico trials for developing andassessing biomedical products / 14 Mar 2017 / 4-6 / Computational modelling; systems biology; tissue mechanics; pharmaceutics; medicine; validation
SC1-PM-17-2017 - Personalised computer models and in-silico systems for well-being / 14 Mar 2017 / 4-6 / Integrative dynamic computer models & simulations; predictive & preventive approaches- medicine, neuroscience
SC1-PM-18-2016 - Big Data supporting Public Health policies / 16 Feb 2016 / 3-5 / How to better acquire, manage, share, model, process, exploit data; governance of big data; support PHA
SC1-PM-19-2017 - PPI for uptake of standards for the exchange of digitalised healthcare records / 14 Mar 2017 / - / Deploy an eHealth infrastructure; sharing of health information – use of Electronic Health Records
SC1-PM-20-2017 - Development of new methods for improved economic evaluation and efficiency measures in the health sector [RTD] / 11 Apr 2017 / - / No info yet
1.6 Health care provision and integrated care / SC1-PM-21-2016 - Implementation research for scaling-up of evidence based innovations and good practice in Europe and low & middle income countries / 13 Apr 2016 / 4-6 / Scale-up a comprehensive intervention (not for 1 single disease); make health systems & services more responsive; person-centred, safe, effective, efficient; facilitators & barriers to scale-up
Coordination activities / SC1-HCO-01- 2016 - Valorisation of FP7 Health and H2020 SC1 research results [CSA] / 13 Apr 2016 / 2 / Develop a European web marketplace referencing all types of innovations from FP7
SC1-HCO-02-2016 - Standardisation of pre-analytical and analytical procedures for in vitro diagnostics in personalised medicine [CSA] / 13 Apr 2016 / 2 / Pan-European quality assurance schemes guidelines - pre-analytical procedures; harmonisation and quality assurance
SC1-HCO-03-2017 - To implement the Strategic Research Agenda on Personalised Medicine [ERA-NET CoFund] / 11 Apr 2017 / 5 / n/a – only public funding agencies may apply (eg MRC)
SC1-HCO-04-2016 - Towards globalisation of the Joint Programming Initiative on Antimicrobial resistance [CSA] / 13 Apr 2016 / 2 / Proposals should support the development and extension of the JPIAMR capacities towards a global initiative.
SC1-HCO-05-2016 - Coordinating personalised medicine research / 13 Apr 2016 / 2 / Development and operations of a European platform for collaboration between funders of personalised medicine
SC1-HCO-06-2016 - Towards an ERA-NET for building sustainable and resilient healthcare models [CSA] / 13 Apr 2016 / 2 / Pave the way to an ERA-NET co-fund action for building sustainable and resilient health care models
SC1-HCO-07-2017 - Global Alliance for Chronic Diseases [RIA] / 11 Apr 2017 / 24 / No information available
SC1-HCO-08-2017 - Actions to bridge the divide in European health research and innovation [CSA] / 11 Apr 2017 / 1 / Actions that can help less performing countries and regions to build capacities and exploit opportunities for H2020
Coordination activities / SC1-HCO-11-2016 – EU mHealth hub including evidence for integration of mHealth in institutional care [CSA] / 16 Feb 2016 / 3
SC1-HCO-12-2016 – Support for Europe’s leading Health ICT SMEs [CSA] / 3
SC1-HCO-13-2016 – Coordinated Action to support the recognition of Silver Economy opportunities arising from demographic change [CSA] / 1
SC1-HCO-14-2016 – Digital health literacy and workforce ICT skills [CSA] / 2.5
SC1-HCO-15-2016 – EU-US interoperability roadmap [CSA] / 1
SC1-HCO-16-2016 – EU eHealth interoperability conformity assessment [CSA] / 1
SC1-HCO-17-2016 – Standardisation needs in the field of ICT for Active & Healthy Ageing [CSA] / 1
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge ‘Health, demographic change and well-being’.
Beneficiaries will be allowed to charge the cost of clinical trials on the basis of unit costs established in line with a methodology set up in a Commission Decision which is expected to be adopted and made available on the Participant Portal.
Except for the SME instrument, the thresholds for each criterion in a single stage process will be 4, 4 and 3. The cumulative threshold will be 12.
SME Instrument:
Topic id & titleSMEInst05-2016+2017 - Supporting innovative SMEs in the healthcare biotechnology sector [RTD - SME Instrument] [phase 1 and 2]
a.Cell technology in medical applications[phase 1 and 2]
b.Clinical research for the validation of biomarkers and/or diagnostic medical devices [2017 only]
SMEInst06-2016+2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
a. Support for European eHealth SMEs [CNECT- SME Instrument]
b. ICT solutions for Active and Healthy Ageing based on open platforms [CNECT- SME Instrument]